Abbott Laboratories (ABT)

Abbott hosts conference call for second-quarter earnings

Abbott hosts conference call for second-quarter earnings PR Newswire ABBOTT PARK, Ill., June 25, 2026 ABBOTT PARK, Ill., June 25, 2026...

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing PR Newswire CARLSBAD, Calif., June 24...

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for...

Form 4 - Statement of changes in beneficial ownership of securities

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Abbott declares 410th consecutive quarterly dividend

Abbott declares 410th consecutive quarterly dividend PR Newswire ABBOTT PARK, Ill., June 12, 2026 ABBOTT PARK, Ill., June 12, 2026...

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired...

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis PR Newswire ABBOTT PARK, Ill., June 6...

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes PR...

Form SD - Specialized disclosure report

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes PR...

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening PR Newswire ABBOTT PARK, Ill., May 27, 2026...

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 PR Newswire ABBOTT PARK, Ill., May 26, 2026 Data...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities